chr7-30594717-C-T

Variant names:

• chr7-30594717-C-T
• rs17159262
• ENST00000675051.1:c.22-4079C>T

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_Strong BP6_Very_Strong BS1 BS2

The ENST00000675051.1(GARS1):​c.22-4079C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0251 in 596,034 control chromosomes in the GnomAD database, including 220 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

• Frequency:
  • Genomes: 𝑓 0.029 (77 hom., cov: 33)
  • Exomes 𝑓: 0.024 (143 hom.)
• Consequence: GARS1 ENST00000675051.1 intron
• Clinical Significance: Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5
• Conservation: PhyloP100: 1.05

Genes affected

GARS1 (HGNC:4162): (glycyl-tRNA synthetase 1) This gene encodes glycyl-tRNA synthetase, one of the aminoacyl-tRNA synthetases that charge tRNAs with their cognate amino acids. The encoded enzyme is an (alpha)2 dimer which belongs to the class II family of tRNA synthetases. It has been shown to be a target of autoantibodies in the human autoimmune diseases, polymyositis or dermatomyositis. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2015]

GARS1-DT (HGNC:48951): (GARS1 divergent transcript)

ACMG classification

Verdict is Benign. Variant got -20 ACMG points.

• BP4: Computational evidence support a benign effect (BayesDel_noAF=-0.75).
• BP6: Variant 7-30594717-C-T is Benign according to our data. Variant chr7-30594717-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 359994.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr7-30594717-C-T is described in Lovd as [Benign].
• BS1: Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.0287 (4378/152320) while in subpopulation AFR AF= 0.0343 (1427/41568). AF 95% confidence interval is 0.0328. There are 77 homozygotes in gnomad4. There are 2041 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
• BS2: High AC in GnomAd4 at 4378 AD gene.

Transcripts

RefSeq

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	MANE	Protein	UniProt
GARS1	NM_002047.4	c.-205C>T		upstream_gene_variant		ENST00000389266.8	NP_002038.2
GARS1	NM_001316772.1	c.-367C>T		upstream_gene_variant			NP_001303701.1

Ensembl

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	TSL	MANE	Protein	Appris	UniProt
GARS1	ENST00000675051.1	c.22-4079C>T		intron_variant	Intron 1 of 16			ENSP00000502296.1
GARS1	ENST00000389266.8	c.-205C>T		upstream_gene_variant		1	NM_002047.4	ENSP00000373918.3
GARS1	ENST00000675651.1	c.-205C>T		upstream_gene_variant				ENSP00000502513.1
GARS1	ENST00000675810.1	c.-205C>T		upstream_gene_variant				ENSP00000502743.1
GARS1	ENST00000675693.1	c.-205C>T		upstream_gene_variant				ENSP00000502174.1
GARS1	ENST00000674815.1	c.-383C>T		upstream_gene_variant				ENSP00000502799.1
GARS1	ENST00000674851.1	c.-419C>T		upstream_gene_variant				ENSP00000502451.1
GARS1	ENST00000444666.6	n.-205C>T		upstream_gene_variant		3		ENSP00000415447.2
GARS1	ENST00000674616.1	n.-205C>T		upstream_gene_variant				ENSP00000502408.1
GARS1	ENST00000674643.1	n.-205C>T		upstream_gene_variant				ENSP00000501636.1
GARS1	ENST00000674737.1	n.-205C>T		upstream_gene_variant				ENSP00000502464.1
GARS1	ENST00000674807.1	n.-205C>T		upstream_gene_variant				ENSP00000502814.1
GARS1	ENST00000675529.1	n.-205C>T		upstream_gene_variant				ENSP00000501655.1
GARS1	ENST00000675859.1	n.-205C>T		upstream_gene_variant				ENSP00000502033.1
GARS1	ENST00000676088.1	n.-205C>T		upstream_gene_variant				ENSP00000501884.1
GARS1	ENST00000676140.1	n.-205C>T		upstream_gene_variant				ENSP00000502571.1
GARS1	ENST00000676164.1	n.-205C>T		upstream_gene_variant				ENSP00000501986.1
GARS1	ENST00000676210.1	n.-205C>T		upstream_gene_variant				ENSP00000502373.1
GARS1	ENST00000676259.1	n.-205C>T		upstream_gene_variant				ENSP00000501980.1
GARS1	ENST00000676403.1	n.-205C>T		upstream_gene_variant				ENSP00000502681.1

Frequencies

GnomAD3 genomes AF: 0.0287 AC: 4368 AN: 152202 Hom.: 75 Cov.: 33

Gnomad AFR AF: 0.0342

Gnomad AMI AF: 0.155

Gnomad AMR AF: 0.0279

Gnomad ASJ AF: 0.0202

Gnomad EAS AF: 0.000192

Gnomad SAS AF: 0.00373

Gnomad FIN AF: 0.0122

Gnomad MID AF: 0.0411

Gnomad NFE AF: 0.0309

Gnomad OTH AF: 0.0244

GnomAD4 exome AF: 0.0239 AC: 10607 AN: 443714 Hom.: 143 Cov.: 4 AF XY: 0.0228 AC XY: 5349 AN XY: 234438

Gnomad4 AFR exome AF: 0.0330

Gnomad4 AMR exome AF: 0.0203

Gnomad4 ASJ exome AF: 0.0199

Gnomad4 EAS exome AF: 0.0000673

Gnomad4 SAS exome AF: 0.00733

Gnomad4 FIN exome AF: 0.0134

Gnomad4 NFE exome AF: 0.0302

Gnomad4 OTH exome AF: 0.0280

GnomAD4 genome AF: 0.0287 AC: 4378 AN: 152320 Hom.: 77 Cov.: 33 AF XY: 0.0274 AC XY: 2041 AN XY: 74492

Gnomad4 AFR AF: 0.0343

Gnomad4 AMR AF: 0.0278

Gnomad4 ASJ AF: 0.0202

Gnomad4 EAS AF: 0.000193

Gnomad4 SAS AF: 0.00373

Gnomad4 FIN AF: 0.0122

Gnomad4 NFE AF: 0.0309

Gnomad4 OTH AF: 0.0241

Alfa AF: 0.0290 Hom.: 13

Bravo AF: 0.0306

Asia WGS AF: 0.00577 AC: 20 AN: 3478

ClinVar

Significance: Benign/Likely benign

Submissions summary: Benign:5

Revision: criteria provided, multiple submitters, no conflicts

Submissions by phenotype

not provided Benign:2

-

Breakthrough Genomics, Breakthrough Genomics

Significance: Likely benign

Review Status: criteria provided, single submitter

Collection Method: not provided

- -

Jun 14, 2018

GeneDx

Significance: Likely benign

Review Status: criteria provided, single submitter

Collection Method: clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Distal spinal muscular atrophy Benign:1

Jan 12, 2018

Illumina Laboratory Services, Illumina

Significance: Benign

Review Status: criteria provided, single submitter

Collection Method: clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Charcot-Marie-Tooth disease type 2D Benign:1

Jan 12, 2018

Illumina Laboratory Services, Illumina

Significance: Benign

Review Status: criteria provided, single submitter

Collection Method: clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Neuronopathy, distal hereditary motor, type 5A Benign:1

Jan 12, 2018

Illumina Laboratory Services, Illumina

Significance: Benign

Review Status: criteria provided, single submitter

Collection Method: clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name	Calibrated prediction	Score	Prediction
BayesDel_noAF	Benign	-0.75
CADD	Benign	7.4
DANN	Benign	0.82

Splicing

Name	Calibrated prediction	Score	Prediction
SpliceAI score (max)		0.0		Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Other links and lift over

dbSNP: rs17159262; hg19: chr7-30634333;